News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-457

Look a little deeper mate, what does BIT also have apart from ‘hype’? ....

Perhaps this; the ability to have cashed in on that ‘hype’, when has anyone ‘cashed’ in on options for Admedus in recent times?

Great outcome for the future would be to see its 8 cent options taken up.

What has cost Admedus it’s resulting poor sentiment?? .... despite 24 or so mill revenue plus promising IP??

Talking to myself I guess, lol, but never mind.